Quantcast
Last updated on May 24, 2013 at 20:22 EDT

Latest Biology Stories

2013-05-22 08:29:34

Studies show superiority of AE37 among peptide cancer vaccines WORCESTER, Mass. and TORONTO, May 22, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced three presentations demonstrating the superiority of the AE37 breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). The presentations will be made at the annual meeting of the American Society of Clinical Oncology (ASCO)...

2013-05-22 08:29:15

Exciting new precision medicine tool for diagnosing and guiding treatment of patients with NEPC Prostate Cancer BUFFALO, N.Y., May 22, 2013 /PRNewswire/ -- Empire Genomics announced today it has acquired an exclusive license for a patent pending novel genomic biomarker from Cornell University for use in developing a molecular diagnostic test that could help in diagnosing and determining treatment for patients with neuroendocrine (NEPC) prostate cancer. Neuroendocrine prostate...

2013-05-22 08:29:12

Study results presented at annual meeting of American Thoracic Society (ATS) PHILADELPHIA, May 22, 2013 /PRNewswire/ -- Grifols, a global healthcare company based in Barcelona, Spain, presented results from a study demonstrating that a higher dose of PROLASTIN(©)-C (Alpha(1)-Proteinase Inhibitor [Human]) increased levels of the alpha(1) protein in patients with alpha(1)antitrypsin (AAT) deficiency to levels that are considered within the normal range for healthy individuals. AAT...

2013-05-22 08:28:27

PALO ALTO, Calif., May 22, 2013 /PRNewswire/ -- Cellular Biomedicine Group (OTCQB: CBMG) today announced that it has achieved half of the enrollment of the total projected enrollment required for its Phase I trial to evaluate the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common type of liver cancer. To date the trial has had no Severe Adverse Effect (SAE) reported. The Phase I clinical trial...

2013-05-22 08:28:18

SAN DIEGO, May 22, 2013 /PRNewswire/ -- Ambit Biosciences Corporation (Nasdaq: AMBI) today announced that data from clinical investigations of quizartinib (AC220), a potent and selective FLT3 inhibitor, will be presented at the Annual Meeting of the American Society of Clinical Oncology, held May 31 through June 4, 2013, at McCormick Place in Chicago. Information about the abstracts, including presentation time and location, is listed below. Abstracts can be viewed online at...

2013-05-22 08:27:43

NEWARK, Del., May 22, 2013 /PRNewswire/ -- PRNewswire - iBio, Inc. (NYSE MKT: IBIO) today announced the production of a vaccine candidate for the newly emerged H7N9 influenza virus by an independent third party laboratory using the iBioLaunch(TM) platform. This validation milestone was achieved in 21 days as measured from initial antigen sequence information to purification of recombinant protein. (Logo: http://photos.prnewswire.com/prnh/20120419/NY91086LOGO ) The iBioLaunch...

2013-05-22 08:27:30

SEATTLE, May 22, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the following two conferences: 38(th) Annual Deutsche Bank dbAccess Health Care ConferenceMay 29, 20132:10 p.m. EDTBoston, MA...

2013-05-22 08:27:27

PRINCETON, N.J., May 22, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the US Patent and Trademark Office granted patent 8,444,991 entitled "Method of Preparing an Immunologically-Active Adjuvant-Bound Dried Vaccine Composition." The new patent's claims...

2013-05-22 08:27:15

IRVINE, Calif., May 22, 2013 /PRNewswire/ -- ZO Skin Health, Inc. is pleased to announce that they will host a series of educational seminars and webinars on "Expanded Concepts and Principles of Skin Health Science", created and presented by internationally renowned dermatologist Zein Obagi, MD, along with ZO faculty member, professional colleague and board-certified dermatologist Monika Kiripolsky, MD. Each seminar and webinar is specifically designed by Dr. Obagi to educate...

2013-05-22 08:26:45

Renowned lipidologist will discuss discordance in apoB and LDL-P study and interpretations for clinical practice RICHMOND, Va., May 22, 2013 /PRNewswire/ -- Dr. Thomas Dayspring, a Health Diagnostic Laboratory, Inc. Medical Advisory Board member known as "Dr. Lipid" in lipidology and Twitter circles, will give an oral presentation during a live session at the National Lipid Association's Scientific Sessions 2013 on May 31 at 12 p.m. in Las Vegas. In addition, Dr. Dayspring - an NLA...


Latest Biology Reference Libraries

Protein Synthesis
2013-05-20 09:21:29

The activity of any living cell, and by extension life itself, depends on protein synthesis and the transcription of DNA. If proteins are the machinery of cellular function, then DNA are the machine assembly lines – responsible for accurately and efficiently ‘transcribing’ protein messengers, structures and enzymes. DNA transcription begins in the nucleus of a cell when an enzyme called RNA polymerase binds to the DNA strand. Sequences within the DNA direct the polymerase to...

Seed Saving
2013-05-18 07:22:11

Seed saving is the preserving of seeds from mature vegetables, herbs, and flowers used in subsequent years along with bulbs and tubers. Home gardeners have saved seeds for generations and the practice is now becoming common with organic farmers as well as permaculturists. Growers will clone plants so as not to produce seeds keeping the plant “true to type” to the parent plant. True to type refers to the characteristics of the parent plant such as large fruit/blooms. Plants...

Variable bushy feather star, Comaster Schlegelii
2013-05-18 06:46:30

The Variable bushy feather star is commonly found concealed on shallow water reefs in the western Pacific Ocean. The parts that will be most often seen are the fern-like arms. The arms start at the base with five rays then begin to divide from there. The arms are flexible due to the multiple calcium filled joints, also called ossicle; therefore if needed these arms could coil up and provide protection to the main body. Interestingly, if one arm should fall off, or perhaps pulled off, then two...

Noble feather star, Comaster nobilis
2013-05-18 06:36:19

The noble feather star (also known as the yellow feather star) reaches up to 15.75 inches in diameter with a cup-shaped body. There can be 35-40 arms extending out of the central part of the body. The arms are primarily yellow with the underside having a variation to include black, green, or white. The noble feather star feeds on food debris, phytoplankton and zooplankton. Phytoplankton and zooplankton are microscopic organisms that are present mainly in the layer of the oceans that is...

Mediterranean feather star, Antedon mediterranea
2013-05-18 06:26:42

The Mediterranean feather star is a filter feeder that obtains food by straining suspended matter and food particles from water. The star has a stalk that has up to forty tendrils, (threadlike organs) which help the star cling to hard surfaces. The “body” of the star is called a calyx and is shaped like a small cup. This calyx is surrounded by feathery pinnules bearing arms. These arms are quite unique in the fact that they can regenerate if one should get broken off; these arms extend to...

More Articles (1228 articles) »